Xeris Biopharma Holdings Inc.

05/12/2022 | Press release | Distributed by Public on 05/12/2022 14:04

Xeris Announces Full Results From the Logics Study of Recorlev® and Presentation of New Burden of Illness in Cushing’s Syndrome Data at AACE Annual Meeting May 12-14